Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label extension and long-term follow-up study of atezolizumab in prior Genentech/Roche trials
jRCT2080223996Phase 3Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Aug 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 3, open-label trial of atezolizumab in cancer (2 arms), sponsored by Chugai Pharmaceutical Co., Ltd. Started Aug 2018; status: completed.
02
Drugs
atezolizumab
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080223996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223996.